Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38

被引:312
作者
Bai, Xiaochun
Ma, Dongzhu
Liu, Anling
Shen, Xiaoyun
Wang, Qiming J.
Liu, Yongjian
Jiang, Yu
机构
[1] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA
[3] So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Peoples R China
关键词
D O I
10.1126/science.1147379
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase ( GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein ( FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)-dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.
引用
收藏
页码:977 / 980
页数:4
相关论文
共 20 条
  • [1] The Rheb family of GTP-binding proteins
    Aspuria, PJ
    Tamanoi, F
    [J]. CELLULAR SIGNALLING, 2004, 16 (10) : 1105 - 1112
  • [2] Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin
    Edlich, F
    Weiwad, M
    Erdmann, F
    Fanghänel, J
    Jarczowski, F
    Rahfeld, JU
    Fischer, G
    [J]. EMBO JOURNAL, 2005, 24 (14) : 2688 - 2699
  • [3] The specific FKBP38 inhibitor N-(N′,N′-dimethylcarboxamidomethyl) cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia
    Edlich, Frank
    Weiwad, Matthias
    Wildemann, Dirk
    Jarczowski, Franziska
    Kilka, Susann
    Moutty, Marie-Christine
    Jahreis, Guenther
    Luecke, Christian
    Schmidt, Werner
    Striggow, Frank
    Fischer, Gunter
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (21) : 14961 - 14970
  • [4] The mode of action of peptidyl prolyl cis/trans isomerases in vivo:: binding vs. catalysis
    Fischer, G
    Tradler, T
    Zarnt, T
    [J]. FEBS LETTERS, 1998, 426 (01): : 17 - 20
  • [5] Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
    Garami, A
    Zwartkruis, FJT
    Nobukuni, T
    Joaquin, M
    Roccio, M
    Stocker, H
    Kozma, SC
    Hafen, E
    Bos, JL
    Thomas, G
    [J]. MOLECULAR CELL, 2003, 11 (06) : 1457 - 1466
  • [6] Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
    Hara, K
    Maruki, Y
    Long, XM
    Yoshino, K
    Oshiro, N
    Hidayat, S
    Tokunaga, C
    Avruch, J
    Yonezawa, K
    [J]. CELL, 2002, 110 (02) : 177 - 189
  • [7] Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
    Inoki, K
    Li, Y
    Xu, T
    Guan, KL
    [J]. GENES & DEVELOPMENT, 2003, 17 (15) : 1829 - 1834
  • [8] MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
    Kim, DH
    Sarbassov, DD
    Ali, SM
    King, JE
    Latek, RR
    Erdjument-Bromage, H
    Tempst, P
    Sabatini, DM
    [J]. CELL, 2002, 110 (02) : 163 - 175
  • [9] TSC2: filling the GAP in the mTOR signaling pathway
    Li, Y
    Corradetti, MN
    Inoki, K
    Guan, KL
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (01) : 32 - 38
  • [10] Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity
    Li, Y
    Inoki, K
    Guan, KL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (18) : 7965 - 7975